Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gunung Raja Paksi Tbk. (GGRP) vs Indofarma Tbk. (INAF) Price & Performance

Gunung Raja Paksi Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

Gunung Raja Paksi Tbk. vs Indofarma Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp330 (market cap 4.02T, 1.49M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Gunung Raja Paksi Tbk. is far larger — about 10.3× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

GGRPINAF
Market Cap
4.02T390.51B
Volume
1.49M
Lot
14.87K
Turnover
488.12M
Average Price
328.37
Value
488.12M
Indicative Equilibrium Price
330
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GGRP
View details
INAF
View details

About Gunung Raja Paksi Tbk.

PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.

Read more on GGRP

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF